RxDoctor Payments DataLook up a doctor →

Fortune Alabi, MD

Critical Care Medicine · Kissimmee, FLNPI 1124025309

Payments from drug & device makers

$3,202,112in general payments, 2019–2025

Across 2,814 payments — averaging $1137.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$850K
  • Boehringer Ingelheim$567K
  • Insmed, Inc.$479K
  • GSK$388K
  • AstraZeneca$309K
  • Roche Products Limited$131K
  • plus $476K from 54 others
$2,008in research payments, 2019–2025

Across 3 payments — averaging $669.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Chiesi USA, Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.36$850,496
Boehringer Ingelheim395$567,352
Insmed, Inc.466$479,306
GSK254$388,330
AstraZeneca383$309,205
Roche Products Limited16$130,916
Sanofi81$98,534
Mallinckrodt Hospital Products Inc.69$79,432
Regeneron71$50,835
Boehringer Ingelheim International GmbH94$41,834
Eisai Inc.31$41,215
ANI Pharmaceuticals, Inc.69$38,381
Cipla USA Inc.12$28,858
United Therapeutics Corporation96$25,852
Regeneron Healthcare Solutions, Inc.88$20,728
Amgen20$8,511
Actelion Pharmaceuticals US, Inc.116$7,713
Pfizer13$6,886
Genentech USA, Inc.40$5,815
Verona Pharma, Inc.18$5,783
Jazz Pharmaceuticals Inc.53$2,012
Viiv Healthcare Company1$1,600
Philips North America LLC62$1,403
Novartis24$1,281
Grifols USA, LLC44$1,027
Harmony Biosciences LLC23$824
Edwards Lifesciences10$809
Bayer32$648
Takeda Pharmaceuticals U.S.A., Inc.25$561
Mylan Specialty L.p.21$437
Paratek Pharmaceuticals, Inc.11$410
Pulmonx Corporation4$395
Johnson & Johnson(2 entities)10$385
Axsome Therapeutics, Inc.17$374
ZOLL Respicardia, Inc.1$312
Sanofi-aventis U.S. LLC3$286
Avadel CNS Pharmaceuticals, LLC7$272
Merck12$260
Inspire Medical Systems, Inc.3$248
Vapotherm Inc4$226
AbbVie3$225
Genentech, Inc.3$224
Electromed, Inc.16$221
Biomerieux Inc2$189
Sunovion Pharmaceuticals Inc.10$173
Gilead(2 entities)3$150
La Jolla Pharmaceutical Company1$129
Idorsia Pharmaceuticals US Inc2$125
Sandoz6$121
Vertex1$120
Teva Pharmaceuticals USA, Inc.6$101
Vifor Pharma, Inc.3$81
Grifols Shared Services North America, Inc.1$80
Viatris Specialty LLC3$75
Fisher & Paykel Healthcare Inc4$74
Mallinckrodt Enterprises LLC2$46
Itamar Medical Inc2$39
Inogen, Inc.2$35
Liquidia Technologies, Inc.1$25
Tactile Systems Technology Inc1$18

How this compares

$3,202,112 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.

See all critical care medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$1,085,400
Medicare patients
1,149
Services billed
23,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Kissimmee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →